| Attributes | Values |
|---|
| rdf:type
| |
| description
| - wetenschappelijk artikel (nl)
- articolo scientifico (pubblicato il 1996) (it)
- наукова стаття, опублікована в лютому 1996 (uk)
- im Januar 1996 veröffentlichter wissenschaftlicher Artikel (de)
- artículu científicu espublizáu en xineru de 1996 (ast)
- artikull shkencor i botuar më 01 janar 1996 (sq)
- scientific article published on 01 January 1996 (en)
- գիտական հոդված հրատարակված 1996 թվականի հունվարի 1-ին (hy)
|
| publication date
| |
| publication date
| |
| language of work or name
| |
| language of work or name
| |
| exact match
| |
| exact match
| |
| cites work
| |
| cites work
| - A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma
- Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancer.
- Effect of Age on Incidence of Breast Cancer in Females2
- A randomized phase I and II study of short-term infusion of high-dose fluorouracil with or without N-(phosphonacetyl)-L-aspartic acid in patients with advanced pancreatic and colorectal cancers
- Combination Chemotherapy for Advanced Breast Cancer: Response and Effect on Survival
- Dihydroxyanthracenedione: a promising new drug in the treatment of metastatic breast cancer.
- Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer
- A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma
- Clinical trials and drug toxicity in the elderly. The experience of the Eastern Cooperative Oncology Group
- A randomized multicenter trial comparing mitoxantrone, cyclophosphamide, and fluorouracil with doxorubicin, cyclophosphamide, and fluorouracil in the therapy of metastatic breast carcinoma
- Refractory metastatic breast cancer: salvage therapy with fluorouracil and high-dose continuous infusion leucovorin calcium.
- Phase II study of mitoxantrone, leucovorin, and infusional fluorouracil for treatment of metastatic breast cancer
- Mitoxantrone, fluorouracil, and high-dose leucovorin: an effective, well-tolerated regimen for metastatic breast cancer
- 5-Fluorouracil plus leucovorin in women with metastatic breast cancer. A phase II study
- The Eastern Cooperative Oncology Group experience with cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in patients with metastatic breast cancer
- The emerging role of 5-fluorouracil and leucovorin in the treatment of advanced breast cancer. A review
- Mitoxantrone, 5-fluorouracil and levo-leucovorin as salvage treatment in advanced breast cancer patients
|
| author name string
| |
| author name string
| - L Gallo
- S Mammoliti
- C Caroti
|
| rdfs:label
| - Phase II study of mitoxantrone, 5-fluorouracil, and levo-leucovorin (MLF) in elderly advanced breast cancer patients (en)
- Phase II study of mitoxantrone, 5-fluorouracil, and levo-leucovorin (MLF) in elderly advanced breast cancer patients (nl)
- Phase II study of mitoxantrone, 5-fluorouracil, and levo-leucovorin (MLF) in elderly advanced breast cancer patients (sq)
|
| skos:prefLabel
| - Phase II study of mitoxantrone, 5-fluorouracil, and levo-leucovorin (MLF) in elderly advanced breast cancer patients (en)
- Phase II study of mitoxantrone, 5-fluorouracil, and levo-leucovorin (MLF) in elderly advanced breast cancer patients (nl)
- Phase II study of mitoxantrone, 5-fluorouracil, and levo-leucovorin (MLF) in elderly advanced breast cancer patients (sq)
|
| name
| - Phase II study of mitoxantrone, 5-fluorouracil, and levo-leucovorin (MLF) in elderly advanced breast cancer patients (en)
- Phase II study of mitoxantrone, 5-fluorouracil, and levo-leucovorin (MLF) in elderly advanced breast cancer patients (nl)
- Phase II study of mitoxantrone, 5-fluorouracil, and levo-leucovorin (MLF) in elderly advanced breast cancer patients (sq)
|
| author
| |
| author
| |
| title
| |
| title
| - Phase II study of mitoxantrone, 5-fluorouracil, and levo-leucovorin (MLF) in elderly advanced breast cancer patients (en)
|
| page(s)
| |
| page(s)
| |
| instance of
| |
| instance of
| |
| main subject
| |
| main subject
| |
| PubMed ID
| |
| PubMed ID
| |
| PubMed ID
| |
| published in
| |
| published in
| |
| issue
| |
| volume
| |
| issue
| |
| volume
| |
| DOI
| |
| DOI
| |
| DOI
| |
| is about
of | |
| is cites work
of | |
| is cites work
of | |
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)